70 related articles for article (PubMed ID: 9588868)
1. Absorption enhancers as tools to determine the route of nasal absorption of peptides.
Donnelly A; Kellaway IW; Taylor G; Gibson M
J Drug Target; 1998; 5(2):121-7. PubMed ID: 9588868
[TBL] [Abstract][Full Text] [Related]
2. The influence of absorption enhancers on nasal absorption of acyclovir.
Chavanpatil MD; Vavia PR
Eur J Pharm Biopharm; 2004 May; 57(3):483-7. PubMed ID: 15093597
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
4. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
5. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD
J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123
[TBL] [Abstract][Full Text] [Related]
6. Nasal drug delivery of sumatriptan succinate.
Chavanpatil MD; Vavia PR
Pharmazie; 2005 May; 60(5):347-9. PubMed ID: 15918583
[TBL] [Abstract][Full Text] [Related]
7. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
8. Transport of a series of D-phenylalanine-glycine hexapeptides across rat alveolar epithelia in vitro.
Evans JP; Tudball N; Dickinson PA; Farr SJ; Kellaway IW
J Drug Target; 1998; 6(4):251-9. PubMed ID: 9894693
[TBL] [Abstract][Full Text] [Related]
9. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
Zaki NM; Awad GA; Mortada ND; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):89-96. PubMed ID: 16942844
[TBL] [Abstract][Full Text] [Related]
10. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
[TBL] [Abstract][Full Text] [Related]
11. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
12. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
13. Review: clinical opportunities provided by the nasal administration of peptides.
Harris AS
J Drug Target; 1993; 1(2):101-16. PubMed ID: 8069548
[TBL] [Abstract][Full Text] [Related]
14. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effects of intra-nasal enkephalins.
Gwak HS; Cho YM; Chun IK
J Pharm Pharmacol; 2003 Sep; 55(9):1207-12. PubMed ID: 14604463
[TBL] [Abstract][Full Text] [Related]
16. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
17. [Effect of absorption enhancers on nasal ginsenoside Rg1 delivery and its nasal ciliotoxicity].
Chen XM; Zhu JB; Sun WD; Zhang LJ
Yao Xue Xue Bao; 2006 Feb; 41(2):149-55. PubMed ID: 16671546
[TBL] [Abstract][Full Text] [Related]
18. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
19. Preparation of prostaglandin E1-hydroxypropyl-beta-cyclodextrin complex and its nasal delivery in rats.
Gu FG; Cui FD; Gao YL
Int J Pharm; 2005 Feb; 290(1-2):101-8. PubMed ID: 15664135
[TBL] [Abstract][Full Text] [Related]
20. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
Baldwin PA; Klingbeil CK; Grimm CJ; Longenecker JP
Pharm Res; 1990 May; 7(5):547-52. PubMed ID: 2367323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]